Skip to content

Bio-Techne TECH Inventories

Inventories at other companies

Danaher logo
DanaherDHR
$2.61B+3.0%
Bruker logo
BrukerBRKR
$1.12B+0.4%
Revvity logo
RevvityRVTY
$387.51M+1.6%
Agilent Technologies logo
Agilent TechnologiesA
$1.09B+9.9%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$359.72M+24.0%
Illumina logo
IlluminaILMN
$20M-96.9%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's inventories?
Bio-Techne (TECH) reported inventories of $201.18M in Q1 2026.
How has Bio-Techne's inventories changed year-over-year?
Bio-Techne's inventories increased by 5.3% year-over-year, from $191.08M to $201.18M.
What is the long-term trend for Bio-Techne's inventories?
Over 3 years (2022 to 2025), Bio-Techne's inventories has grown at a 39.4% compound annual growth rate (CAGR), from $278.11M to $753.94M.
What does inventories mean?
The total value of all products and materials the company currently has in stock.
How do you interpret inventories?
Increasing inventory may signal anticipated demand growth or supply chain hedging, while excessive growth relative to sales can indicate overproduction or slowing demand.
How does inventories compare across companies?
Life sciences manufacturers often hold higher inventory levels to ensure product availability for critical research applications.